Real-time enrollment status for this kcnt1-related epilepsy clinical trial
Current Status
Recruiting
Checked: July 21, 2026 at 10:30 AM UTC
| NCT Number | NCT07600736 |
| Recruiting Status | Recruiting |
| Condition | KCNT1-Related Epilepsy |
| Phase | PHASE2 |
| Target Enrollment | 45 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Actio Biosciences, Inc. |
| Last Updated on CT.gov | June 17, 2026 (Jun 17, 2026) |
As of July 21, 2026: Clinical trial NCT07600736 is currently recruiting participants. This phase2 study for kcnt1-related epilepsy is actively seeking new participants at 1 location across the United States. The study is sponsored by Actio Biosciences, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07600736 is actively recruiting participants as of July 21, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07600736 was last updated Jun 17, 2026 (June 17, 2026). HelloStudys verifies this status automatically.